Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769753 · ClinicalTrials.gov registry record · Phase 2
Trial of IRE in Cholangiocarcinoma
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT03769753: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03769753 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03769753, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to test any good and bad side effects of surgery using IRE to treat cancer of the bile duct.
Interventions
- DEVICE IRE Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2021-08-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03769753
The ClinicalTrials.gov registry entry for NCT03769753 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IRE Device is the first listed.
NCT03769753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03769753 about?
NCT03769753 is a clinical study titled "Trial of IRE in Cholangiocarcinoma". The purpose of this study is to test any good and bad side effects of surgery using IRE to treat cancer of the bile duct.
What is the current status of trial NCT03769753?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2018-12-05. Estimated completion is 2021-08-16.
What interventions are being tested in trial NCT03769753?
The interventions under investigation include: IRE Device (DEVICE).
Who is sponsoring clinical trial NCT03769753?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.